Today’s Price Action: Nobilis Health Corp (USA) Just Recorded A Sigfniciant Decline

Today's Price Action: Nobilis Health Corp (USA) Just Recorded A Sigfniciant Decline

The stock of Nobilis Health Corp (USA) (NYSEMKT:HLTH) is a huge mover today! About 388,551 shares traded hands or 38.27% up from the average. Nobilis Health Corp (USA) (NYSEMKT:HLTH) has declined 20.97% since April 6, 2016 and is downtrending. It has underperformed by 22.93% the S&P500.
The move comes after 6 months negative chart setup for the $199.88M company. It was reported on Nov, 8 by We have $2.16 PT which if reached, will make NYSEMKT:HLTH worth $19.99 million less.

Analysts await Nobilis Health Corp (USA) (NYSEMKT:HLTH) to report earnings on January, 10. They expect $0.08 earnings per share, up 60.00% or $0.03 from last year’s $0.05 per share. HLTH’s profit will be $6.66M for 7.50 P/E if the $0.08 EPS becomes a reality. After $0.06 actual earnings per share reported by Nobilis Health Corp (USA) for the previous quarter, Wall Street now forecasts 33.33% EPS growth.

According to Zacks Investment Research, “Nobilis Health Corp. own and manage ambulatory and acute care facilities for healthcare services. In addition, it owns and manages ambulatory surgery centers, acute care hospital, imaging centers and urgent care clinic. The company operates primarily in Houston, Dallas and Scottsdale, Arizona. Nobilis Health Corp. is headquartered in Houston, Texas.”

More recent Nobilis Health Corp (USA) (NYSEMKT:HLTH) news were published by: which released: “Nobilis Health to Release Third Quarter Earnings & Host Conference Call on …” on November 01, 2016. Also published the news titled: “Here’s Why Nobilis Health Corp (USA) Stock Is down Today” on May 11, 2016.‘s news article titled: “Nobilis Health Corp. Announces Completion of Acquisition of Arizona Vascular …” with publication date: October 28, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment